Brief: Astrazeneca Pharma India June-Quarter PAT 558.3 Million Rupees
14/08/2025 09:38
Aug 14 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS: JUNE-QUARTER PAT 558.3 MILLION RUPEES JUNE-QUARTER REVENUE FROM OPERATIONS 5.26 BILLION RUPEES Source text: [ID:] Further company coverage: ASTR.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan